Showing all 6 results
Adrenochrome Monosemicarbazone Tablet
FreeProduct Composition & Strength
We supply this product as Sugar Coated Tablets (often Orange/Red) to protect the drug from oxidation and light.
Active Ingredient Strength (Standard) Formulation Type Primary Role Adrenochrome Monosemicarbazone 10 mg Sugar Coated Tablet Minor Bleeding / Maintenance Adrenochrome Monosemicarbazone 25 mg / 30 mg Sugar Coated Tablet Surgical Prophylaxis Excipients Q.S. Titanium Dioxide / Sucrose Light Protection Coating Cefdinir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the active ingredient.
Active Ingredient Strength Primary Clinical Function Cefdinir USP/Ph.Eur. 300 mg The Respiratory & Skin Anchor: The definitive therapeutic unit utilized for CAP, Sinusitis, and Skin/Soft Tissue Infections (SSTI). Excipients Proprietary Matrix Crystalline Form Stability: Engineered utilizing specialized binders to maintain the Crystalline Form I of Cefdinir, ensuring maximum shelf-life and predictable intestinal absorption. Cefprozil Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Monohydrate Tablet, packed in high-barrier Alu-Alu blister strips to prevent hydrolytic degradation.
Active Ingredient Strength Primary Clinical Function Cefprozil USP/Ph.Eur. 250 mg The Pediatric & Mild Infection Anchor: Ideal for Pharyngitis, Tonsillitis, and mild skin infections. Cefprozil USP/Ph.Eur. 500 mg The Respiratory & SSTI Macrodose: Utilized for Acute Sinusitis, secondary infections of Bronchitis, and complicated skin infections. Excipients Proprietary Matrix Hydrolysis-Resistant Formulation: Engineered utilizing high-density granulation to protect the monohydrate API from environmental moisture. Cefuroxime Axetil Tablets
FreeProduct Composition & StrengthWe supply this product as a Precision-Blended, Amorphous Solid Dispersion Tablet, packed exclusively in secure, moisture-resistant Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Cefuroxime Axetil USP/Ph.Eur. 250 mg The Pediatric & ENT Anchor: Utilized for Acute Otitis Media, Pharyngitis, and uncomplicated UTIs. Cefuroxime Axetil USP/Ph.Eur. 500 mg The Respiratory Macrodose: Utilized for Community-Acquired Pneumonia, Bronchitis, and early-stage Lyme Disease. Excipients Proprietary Matrix Amorphous Solid Dispersion Technology: Engineered to maintain the API in its highly-soluble amorphous state for maximum clinical cure rates. Cefuroxime Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Amorphous Solid Dispersion Tablet, packed exclusively in secure, moisture-resistant Alu-Alu blister strips to ensure the stability of the hygroscopic prodrug.
Active Ingredient Strength Primary Clinical Function Cefuroxime Axetil USP/Ph.Eur.
(Equivalent to Cefuroxime)250 mg The Pediatric & ENT Anchor: The definitive unit utilized for the treatment of Acute Otitis Media, Pharyngitis, and uncomplicated Urinary Tract Infections. Cefuroxime Axetil USP/Ph.Eur. 500 mg The Respiratory Macrodose: The high-efficacy therapeutic payload required for the management of Community-Acquired Pneumonia, Bronchitis, and early-stage Lyme Disease. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Sodium Lauryl Sulfate / Colloidal Silicon Dioxide / Premium Polymeric Film Diluent / Superdisintegrant / Solubilizer / Glidant / Film-Coating (Engineered specifically utilizing Amorphous Solid Dispersion Technology. Because crystalline Cefuroxime Axetil has near-zero bioavailability, our tablets are engineered to maintain the API in its highly-soluble amorphous state for maximum clinical cure rates). *Pack Sizes: 1×6, 1×10, or 10×10 Alu-Alu Blisters (Optimized specifically for strict 5-to-10 day acute curative regimens).
Cinnarizine & Dimenhydrinate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Immediate-Release Tablet, packed exclusively in secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the active antihistamine salts.
Active Ingredient Strength Primary Clinical Function Cinnarizine BP/USP 20 mg The Peripheral Stabilizer: Stops the influx of calcium into the inner ear hair cells to dampen the physical sensation of vertigo. Dimenhydrinate BP/USP 40 mg The Central Antiemetic: Blocks H1 and muscarinic receptors in the brain to prevent nausea and motion-induced vomiting. Excipients Microcrystalline Cellulose / Maize Starch / Talc / Magnesium Stearate / Croscarmellose Sodium Diluent / Binder / Glidant / Superdisintegrant (Engineered specifically utilizing High-Shear Dry Blending to ensure 100% uniformity of the active APIs, providing a rapid disintegration profile that delivers relief within 30 minutes of ingestion). *Pack Sizes: 10×10 Blisters (Optimized specifically for short-course acute vertigo regimens).
